Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | FATE | BMY | AMGN | REGN | GILD |
Company | Fate Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Regeneron Pharmaceuticals | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 4.79 | 49.16 | 272.14 | 905.66 | 67.09 |
High | 5.02 | 49.47 | 274.48 | 912.74 | 67.68 |
Low | 4.49 | 48.96 | 271.05 | 903.83 | 67.00 |
Last | 4.54 | 48.99 | 273.54 | 907.32 | 67.03 |
Change | -0.24 | -0.15 | +1.63 | +7.16 | +0.08 |
% Change | -5.02% | -0.31% | +0.60% | +0.80% | +0.12% |
Volume | 4,022,036 | 9,134,522 | 2,492,537 | 336,813 | 5,221,651 |
20-Day Average Volume | 2,226,567 | 10,952,916 | 2,216,467 | 442,256 | 6,334,397 |
Previous Close | 4.78 | 49.14 | 271.91 | 900.16 | 66.95 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 6.16 | 50.55 | 271.99 | 929.14 | 69.34 |
20-Day Raw Stochastic | 1.58% | 20.04% | 46.12% | 19.57% | 14.18% |
20-Day Relative Strength | 31.52% | 41.71% | 48.69% | 39.70% | 32.82% |
Weighted Alpha | -48.69 | -25.74 | +11.45 | +14.00 | -20.86 |
Today's Opinion | 24% Buy | 88% Sell | 40% Sell | 24% Buy | 100% Sell |
Previous Opinion | 24% Buy | 88% Sell | 40% Sell | 24% Buy | 100% Sell |
Last Month's Opinion | 80% Buy | 24% Sell | 8% Buy | 80% Buy | 88% Sell |
Performance | |||||
5-Days | |||||
%Chg | -15.61% since 04/16/24 | +1.51% since 04/16/24 | +2.97% since 04/16/24 | +1.47% since 04/16/24 | -0.42% since 04/16/24 |
Low | 4.49 on 04/23/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 891.46 on 04/19/24 | 65.90 on 04/18/24 |
High | 5.63 on 04/17/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 920.73 on 04/19/24 | 67.68 on 04/23/24 |
1-Month | |||||
%Chg | -31.32% since 03/22/24 | -5.66% since 03/22/24 | -0.95% since 03/22/24 | -6.19% since 03/22/24 | -7.68% since 03/22/24 |
Low | 4.49 on 04/23/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 |
High | 7.65 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 976.75 on 03/27/24 | 73.87 on 03/28/24 |
3-Month | |||||
%Chg | -6.00% since 01/23/24 | -2.25% since 01/23/24 | -11.74% since 01/23/24 | -4.95% since 01/23/24 | -15.66% since 01/23/24 |
Low | 4.40 on 01/25/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 |
High | 8.83 on 03/07/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 81.06 on 01/25/24 |
6-Month | |||||
%Chg | +152.22% since 10/23/23 | -12.52% since 10/23/23 | +0.18% since 10/23/23 | +14.05% since 10/23/23 | -13.58% since 10/23/23 |
Low | 1.63 on 10/30/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 769.19 on 10/27/23 | 65.90 on 04/18/24 |
High | 8.83 on 03/07/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 87.86 on 01/19/24 |
Key Statistics | |||||
Market Capitalization, $K | 544,045 | 99,594,944 | 145,845,984 | 98,803,360 | 83,357,904 |
Shares Outstanding, K | 113,817 | 2,026,759 | 536,376 | 109,762 | 1,245,077 |
Annual Sales | 63,530,000 | 45,006,000,000 | 28,190,000,000 | 13,117,200,000 | 27,116,000,000 |
Annual Net Income | -160,930,000 | 8,025,000,000 | 6,717,000,000 | 3,953,600,000 | 5,665,000,000 |
Last Quarter Sales | 1,680,000 | 11,477,000,000 | 8,196,000,000 | 3,434,300,000 | 7,114,000,000 |
Last Quarter Net Income | -44,120,000 | 1,762,000,000 | 767,000,000 | 1,159,600,000 | 1,429,000,000 |
60-Month Beta | 1.66 | 0.39 | 0.58 | 0.11 | 0.19 |
Per-Share Information | |||||
Most Recent Earnings | -0.45 on 02/26/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 11.86 on 02/02/24 | 1.72 on 02/06/24 |
Latest Earnings Date | 05/01/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 23.86 | 9.93 |